Clinical Trial Update: DEMETRA - ADVICE-002-2022 [NA]

View source ↗

Summary

A completed clinical trial (DEMETRA ADVICE-002-2022) sponsored by Advice Pharma Group srl studied obesity-related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Advice Pharma Group srl | Conditions: Obesity, Health Behavior | NA | Status: COMPLETED